1. Anti-tumour activity of navelbine, a new vinca-alkaloid analog;Ashizawa;Gan To Kagaku Ryoho,1993
2. Safety and tolerance of Navelbine in phase I–II clinical trials;Besenval;Semin Oncol,1989
3. A phase I clinical, plasma, and cellular pharmacology study of gemcitabine;Abbruzzese;J Clin Oncol,1991
4. Safety profile of gemcitabine;Tonato;Anticancer Drugs,1995
5. Gemcitabine safety overview;Green;Semin Oncol,1996